Skip to main content
. 2012 Mar 23;7(3):e33452. doi: 10.1371/journal.pone.0033452

Table 1. Sample characteristics with respect to Vitamin D groups.

Deficiency (n = 173) Insufficiency (n = 80) Sufficiency (n = 47) p-value
Age(years) 47.0 (35.0–54.0) 48.0 (39.5–56.5) 52.0 (40.8–64.2) 0.021
Gender 0.134
Male(n = 194) 107(55.2%) 59(30.4%) 28(14.4%)
Female(n = 106) 66(62.3%) 21(19.8%) 19(17.9%)
Median Vitamin D levels (ng/dL) 13.4 (9.9–17.1) 23.5 (21.6–25.6) 34.9 (32.9–41.8) 0.001
BMI (kg/m2) 27.4 (24.8–30.8) 26.7 (23.9–30.1) 26.5 (23.9–29.9) 0.326
PTH (pg/ml) 44.4 (34.3–56.8) 35.6 (26.9–43.9) 38.4 (28.0–48.8) 0.001
Calcium(mg/dl) 9.46 (9.24–9.67) 9.44 (8.92–9.68) 9.49 (9.23–9.71) 0.189
Phosphorus(mg/dl) 3.14 (2.71–3.43) 3.08 (2.88–3.45) 3.18 (2.78–3.61) 0.846
Albumin (g/dl) 4.92 (4.73–5.06) 4.89 (4.57–5.05) 4.80 (4.56–4.97) 0.100
Alkaline Phosphate (U/L) 91 (79–106) 95 (74–108) 97 (72–116) 0.819
Creatinine (mg/dl) 0.77 (0.67–0.86) 0.78 (0.67–0.93) 0.77 (0.66–0.97) 0.370
eGFR (ml/min per 1.73 m2) 105.8 (90–119) 101.7 (90–121) 103.0 (82–116) 0.234
Diagnosed CKD(n = 7) 4 (57.1%) 1 (14.3%) 2 (28.6%) 0.556
Hypertension(n = 78) 45 (57.5%) 19 (24.4%) 14 (17.9%) 0.755
High spot Bp(n = 97) 62 (63.9%) 27 (27.8%) 8 (8.2%) 0.078
Diabetes Mellitus(n = 89) 54 (60.7%) 19 (21.3%) 16 (18.0%) 0.373
Vitamin D Supplement use(n = 74) 36 (48.6%) 19 (25.7%) 19 (25.7%) 0.021
Daily sunlight >30 mins(n = 239) 143 (59.8%) 57 (23.8%) 39 (16.3%) 0.092

Median values and inter quartile ranges are reported.